If You Invested $1000 in Aflac a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Trupanion Grows in Pet Insurance Amid Rising Veterinary Care Costs
Trupanion rides on strong retention, new products and global expansion to boost revenues and outpace its industry peers.
Unum Group to Benefit From Growing Premium Amid Cost Woes
UNM stock gains from improved premium income, higher sales, strong persistency, and effective capital deployment.
Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma
AFL's sales surge in Japan and the United States, but declining cash flows raise questions over its growth flexibility.
Aflac ( AFL ) Upgraded to Buy: Here's What You Should Know
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Berkshire Boosts Mitsui Stake, Increases Investment in Japan
Berkshire lifts its Mitsui stake to more than 10%, deepening its Japan bet with rising dividends, low-cost debt and governance gains.
Globe Life Is Trading at a Discount: Time to Load Up or Hold Off?
GL builds on niche markets and agency expansion to boost premiums but rising expenses and higher debt weigh on margins.
Zacks Industry Outlook Highlights Aflac, Trupanion and Globe Life
Zacks highlights Aflac, Trupanion, and Globe Life as key stocks in the accident & health insurance industry, which faces pricing pressure but benefits from tech adoption, underwriting strength, and growing demand.
3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure
Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Berkshire Boosts Mitsubishi Stake, Increases Investment in Japan
Berkshire lifts its Mitsubishi stake to 10.23%, deepening its Japan bet with rising dividends, low-cost debt and governance gains.
Here's How Much a $1000 Investment in Aflac Made 10 Years Ago Would Be Worth Today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Why Berkshire Hathaway is Expanding Its Investments in Japan?
BRK.B deepens its Japan bets with $23.5B stakes, yen bonds, and rising dividends fueling long-term growth.
All You Need to Know About Aflac ( AFL ) Rating Upgrade to Buy
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GL Outperforms Industry, Trades Above 50-Day SMA: What's Next?
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Unum to Benefit From Growing Premium Amid Rising Expenses
Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.
Aflac Loads the Buyback Cannon as New Sales Signal Strength
AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.
Walt Disney To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday - Aflac ( NYSE:AFL ) , American Public Education ( NASDAQ:APEI )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stephens & Co. cut Atlassian Corporation TEAM price target from $221 to $202.
Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales
AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.
Aflac ( AFL ) EPS Beats Sales Drop 19%
Aflac ( NYSE:AFL ) , a leading provider of supplemental health and life insurance in the U.S. and Japan, reported its Q2 2025 earnings on August 5, 2025. The company reported adjusted earnings per share ( EPS ) of $1.78, beating analyst estimates of $1.70 ( non-GAAP ) , but revenue ( GAAP ) came ...
Aflac ( AFL ) Q2 Earnings and Revenues Top Estimates
Aflac (AFL) delivered earnings and revenue surprises of +4.09% and +2.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From These 4 Insurers This Earnings Season?
Here, we take a look at four insurance stocks, AFL, LMND, HRTG and AIZ, which are set to report second-quarter earnings on Aug. 5.
Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.
Applied Digital's Q4 Earnings & Revenues Meet Estimates, Stock Up
APLD's fiscal Q4 revenues rose 41%, and major CoreWeave contracts helped drive a sharp pre-market stock rally.
Trupanion ( TRUP ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gear Up for Aflac ( AFL ) Q2 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
$1000 Invested In Aflac 5 Years Ago Would Be Worth This Much Today - Aflac ( NYSE:AFL )
Aflac AFL has outperformed the market over the past 5 years by 9.01% on an annualized basis producing an average annual return of 22.97%. Currently, Aflac has a market capitalization of $53.06 billion.
Unum ( UNM ) Lags Q2 Earnings Estimates
Unum (UNM) delivered earnings and revenue surprises of -7.17% and +1.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Aflac ( AFL ) to Report a Decline in Earnings: What to Look Out for
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Massive Allianz Life Hack Exposes 'Majority' Of 1.4 Million American Customer, Employee Records - Allianz ( OTC:ALIZF ) , Clorox ( NYSE:CLX )
In a recent cyberattack, Allianz Life, part of Allianz SE group ALIZF, has confirmed that the personal data of most of its customers, financial professionals and employees has been stolen. What Happened: The breach was confirmed by Allianz Life spokesperson Brett Weinberg to TechCrunch.
Do Options Traders Know Something About Aflac Stock We Don't?
Investors need to pay close attention to AFL stock based on the movements in the options market lately.
5 Brilliant Dividend Stocks to Buy Now and Hold for the Long Term
Looking for a way to boost your passive income? Dividend stocks might just be your golden ticket. Dividend-paying companies share a portion of their profits with shareholders, typically on a quarterly basis. Many investors find this appealing because it creates a steady passive income stream.But ...
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Aflac ( NYSE:AFL )
Aflac AFL has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 12.53%. Currently, Aflac has a market capitalization of $54.59 billion.
UNM Outperforms Industry, Trades at a Premium: Should You Buy the Stock?
Unum Group outperforms in 2025 as core segments expand and the stock trades at a discount to the industry average.
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
Appointment aims to reinforce Bonus Biogroup's leadership at a pivotal moment as the company advances toward Phase 3 clinical trials for its two flagship therapies: BonoFill and MesenCure Appointment aims to reinforce Bonus Biogroup's leadership at a pivotal moment as the company advances toward ...
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
HAIFA, Israel, July 14, 2025 ( GLOBE NEWSWIRE ) -- Bonus Biogroup BONS, a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells ( MSC ) to develop novel tissue engineering and cell therapy solutions, announced the appointment of Professor of Cell ...
GL Stock Trading at a Discount to Industry at 8.22X: Time to Hold?
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
$100 Invested In Aflac 10 Years Ago Would Be Worth This Much Today - Aflac ( NYSE:AFL )
Aflac AFL has outperformed the market over the past 10 years by 1.51% on an annualized basis producing an average annual return of 12.96%. Currently, Aflac has a market capitalization of $56.37 billion.
Barrack, Rodos & Bacine Investigating Data Breach at Aflac
PHILADELPHIA, June 24, 2025 ( GLOBE NEWSWIRE ) -- Barrack, Rodos & Bacine is actively investigating a data breach at Aflac Incorporated.
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Aflac Incorporated Customers Whose Data May Have Been Compromised
NEWTOWN, Pa., June 20, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Aflac Incorporated ( "Aflac" ) . Aflac learned of suspicious activity on its network or about June 12, 2025.
Lynch Carpenter Investigates Claims in Aflac Data Breach
PITTSBURGH, June 20, 2025 ( GLOBE NEWSWIRE ) -- Aflac Incorporated ( "Aflac" ) recently announced a cybersecurity incident, which impacted the personal information of an unknown number of individuals.
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Aflac ( NYSE:AFL )
Aflac AFL has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 12.46%. Currently, Aflac has a market capitalization of $55.67 billion.
5 Dividend Stocks to Buy With $2,000 and Hold Forever
Investing in the stock market is an excellent way to build long-term wealth. For investors seeking passive income, dividend stocks are one way to turn your portfolio into a cash-generating machine. Not only that, but companies that pay dividends consistently tend to outperform those that ...
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFE
AFL, UNM, TRUP, GL and AMSF are poised to gain from rising exposure and tech adoption despite pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.
UNM Stock Trading at a Discount to Industry at 1.23X: Time to Hold?
Unum Group stock rallies on improved premium income, higher sales, strong persistency, favorable benefits experience, as well as effective capital deployment.
Is the Market Bullish or Bearish on Aflac? - Aflac ( NYSE:AFL )
Aflac's AFL short percent of float has risen 4.03% since its last report. The company recently reported that it has 8.35 million shares sold short, which is 1.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.28 days to cover their ...
Seeking a Payday? 3 Dividend Kings Worth a Look: PM, AFL, EMR
These companies have shown incredible resilience historically, surviving through many economic periods while also continuously increasingly rewarding shareholders.
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Aflac ( NYSE:AFL )
Aflac AFL has outperformed the market over the past 5 years by 7.26% on an annualized basis producing an average annual return of 20.51%. Currently, Aflac has a market capitalization of $55.78 billion.
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
